Your browser doesn't support javascript.
loading
Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
Krivdova, Gabriela; Voisin, Veronique; Schoof, Erwin M; Marhon, Sajid A; Murison, Alex; McLeod, Jessica L; Gabra, Martino M; Zeng, Andy G X; Aigner, Stefan; Yee, Brian A; Shishkin, Alexander A; Van Nostrand, Eric L; Hermans, Karin G; Trotman-Grant, Aaron C; Mbong, Nathan; Kennedy, James A; Gan, Olga I; Wagenblast, Elvin; De Carvalho, Daniel D; Salmena, Leonardo; Minden, Mark D; Bader, Gary D; Yeo, Gene W; Dick, John E; Lechman, Eric R.
Afiliación
  • Krivdova G; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S1A5, Canada.
  • Voisin V; The Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada.
  • Schoof EM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Marhon SA; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Murison A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • McLeod JL; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Gabra MM; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Zeng AGX; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S1A5, Canada.
  • Aigner S; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
  • Yee BA; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
  • Shishkin AA; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
  • Van Nostrand EL; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
  • Hermans KG; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Program of Developmental & Stem Cell Biology, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, ON M5G0A4, Canada.
  • Trotman-Grant AC; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Mbong N; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Kennedy JA; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Division of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, Toronto, ON M4N3M5, Canada.
  • Gan OI; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Wagenblast E; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • De Carvalho DD; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Salmena L; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Minden MD; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Bader GD; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S1A5, Canada; The Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada; Department of Computer Science, University of Toronto
  • Yeo GW; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
  • Dick JE; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S1A5, Canada. Electronic address: john.dick@uhnresearch.ca.
  • Lechman ER; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada. Electronic address: eric.lechman@uhnresearch.ca.
Cell Rep ; 38(10): 110481, 2022 03 08.
Article en En | MEDLINE | ID: mdl-35263585
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / MicroARNs Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / MicroARNs Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Canadá